Although EGFR-TKI alone for brain metastasis in EGFR-mutant lung cancer showed outcomes comparable to those obtained with upfront RT followed by EGFR-TKI, a proportion of patients who could not receive RT following intracranial progression had the worst survival in this study. The gene discussed is EGFR; the disease is lung cancer.